Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.

Nelissen HE, Cremers AL, Okwor TJ, Kool S, van Leth F, Brewster L, Makinde O, Gerrets R, Hendriks ME, Schultsz C, Osibogun A, Van't Hoog AH.

BMC Health Serv Res. 2018 Dec 4;18(1):934. doi: 10.1186/s12913-018-3740-3.

2.

Predictive value of the urinary dipstick test in the management of patients with urinary tract infection-associated symptoms in primary care in Indonesia: a cross-sectional study.

Ginting F, Sugianli AK, Kusumawati RL, Parwati I, de Jong MD, Schultsz C, van Leth F.

BMJ Open. 2018 Aug 29;8(8):e023051. doi: 10.1136/bmjopen-2018-023051.

3.

Testing for LTBI: more of the same or a step forward?

van Leth F, Sester M.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):591. doi: 10.5588/ijtld.18.0267. No abstract available.

PMID:
29862938
4.

Time to revise WHO-recommended definitions of MDR-TB treatment outcomes.

Lange C, van Leth F, Mitnick CD, Dheda K, Günther G.

Lancet Respir Med. 2018 Apr;6(4):246-248. doi: 10.1016/S2213-2600(18)30104-8. No abstract available.

PMID:
29595505
5.

Treatment responses in multidrug-resistant tuberculosis in Germany.

Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741.

PMID:
29562987
6.

Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; for TBNET.

Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC.

PMID:
29509468
7.

Relapse-free cure from multidrug-resistant tuberculosis in Germany.

Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Günther G, Salzer HJF, Terhalle E, Rolling T, Glattki G, Müller M, Schuhmann M, Avsar K, Lange C.

Eur Respir J. 2018 Feb 21;51(2). pii: 1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb. No abstract available.

PMID:
29467205
8.

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

van Leth F, Günther G, Hoffmann H, Lange C; European MDR-TB Database Collaboration.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1489-1490. doi: 10.1164/rccm.201705-0995LE. No abstract available.

PMID:
28715229
9.

Treatment outcomes of MDR-TB and HIV co-infection in Europe.

Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet.

Eur Respir J. 2017 Jun 8;49(6). pii: 1602363. doi: 10.1183/13993003.02363-2016. Print 2017 Jun. No abstract available.

10.

An easy tool to assess ventilation in health facilities as part of air-borne transmission prevention: a cross-sectional survey from Uganda.

Brouwer M, Katamba A, Katabira ET, van Leth F.

BMC Infect Dis. 2017 May 3;17(1):325. doi: 10.1186/s12879-017-2425-6.

11.

Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.

Ssengooba W, Lukoye D, Meehan CJ, Kateete DP, Joloba ML, de Jong BC, Cobelens FG, van Leth F.

Int J Tuberc Lung Dis. 2017 May 1;21(5):531-536. doi: 10.5588/ijtld.16.0544.

PMID:
28399968
12.

Rapid assessment of antimicrobial resistance prevalence using a Lot Quality Assurance sampling approach.

van Leth F, den Heijer C, Beerepoot M, Stobberingh E, Geerlings S, Schultsz C.

Future Microbiol. 2017 Apr;12:369-377. doi: 10.2217/fmb-2016-0170. Epub 2017 Mar 24.

PMID:
28339294
13.

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

Dedicoat MJ, Günther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C; for TBNET ‡.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1222-1224. doi: 10.1164/rccm.201612-2585LE. No abstract available.

PMID:
28323453
14.

Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.

Sugianli AK, Ginting F, Kusumawati RL, Pranggono EH, Pasaribu AP, Gronthoud F, Geerlings S, Parwati I, De Jong MD, Van Leth F, Schultsz C.

J Antimicrob Chemother. 2017 May 1;72(5):1469-1477. doi: 10.1093/jac/dkw578.

15.

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Lange C, Günther G, van Leth F; TBNET.

N Engl J Med. 2016 Dec 29;375(26):2611. doi: 10.1056/NEJMc1613123. No abstract available.

PMID:
28029919
16.

Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.

Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1265-1271. Epub 2016 Oct 17.

17.

Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.

Bruins WS, van Leth F.

Infect Dis (Lond). 2017 Mar;49(3):161-169. doi: 10.1080/23744235.2016.1262059. Epub 2016 Dec 2. Review. Erratum in: Infect Dis (Lond). 2017 Apr;49(4):320.

PMID:
27911140
18.

Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.

Senkoro M, Kumar AM, Chinnakali P, Mfinanga SG, Egwaga S, Kamara V, van Leth F, Hinderaker SG.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1326-1333. Erratum in: Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1070.

PMID:
27725043
19.

Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.

Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F; European MDR-TB database collaboration *.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. No abstract available.

PMID:
27685538
20.

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET.

N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274. No abstract available.

PMID:
27626539

Supplemental Content

Loading ...
Support Center